- Home
- BLDR vs EXEL Comparison
BLDR vs EXEL Comparison
Compare BLDR & EXEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BLDR | EXEL |
|---|---|---|
| Founded | 1998 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | RETAIL: Building Materials | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.7B | 11.4B |
| IPO Year | 2005 | 2000 |
Fundamental Metrics
Financial Performance| Metric | BLDR | EXEL |
|---|---|---|
| Price | $82.04 | $43.94 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 18 | 21 |
| Target Price | ★ $132.29 | $46.45 |
| AVG Volume (30 Days) | 2.1M | ★ 2.1M |
| Earning Date | 04-30-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 57.95 |
| EPS | ★ 3.89 | 2.78 |
| Revenue | ★ $15,190,638,000.00 | $452,477,000.00 |
| Revenue This Year | $1.00 | $13.66 |
| Revenue Next Year | $4.52 | $13.39 |
| P/E Ratio | $20.34 | ★ $15.78 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $76.50 | $32.38 |
| 52 Week High | $151.03 | $48.74 |
Technical Indicators
Market Signals| Indicator | BLDR | EXEL |
|---|---|---|
| Relative Strength Index (RSI) | 38.59 | 60.20 |
| Support Level | $80.00 | $40.42 |
| Resistance Level | $130.47 | $45.88 |
| Average True Range (ATR) | 3.65 | 0.94 |
| MACD | 0.59 | 0.35 |
| Stochastic Oscillator | 36.64 | 93.87 |
Price Performance
Historical ComparisonAbout BLDR Builders FirstSource Inc.
Builders FirstSource Inc is a manufacturer and supplier of building materials. The company offers structural and related building products such as factory-built roof and floor trusses, wall panels and stairs, vinyl windows, custom millwork and trim, and engineered wood. The products can be designed for each home individually and are installed by Builders FirstSource. The company's construction-related services include professional installation, turn-key framing, and shell construction. Builders FirstSource's customers range from large production builders to small custom homebuilders.
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.